About Shennon Biotechnologies
Shennon Biotechnologies is a private company based in San Francisco, California, incorporated in 2021 in Delaware. It has reported $7,299,925 raised in one offering on Form D since March 2023. Its chief executive is Li Sun.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 21, 2022 | Mar 16, 2023 | $7,299,925fully sold | 9 | $811K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Shennon Biotechnologies's Form D filed Mar 16, 2023.
JH
James Hardiman
Director
LS
Li Sun
Chief Executive Officer and director